Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cell cultures "poor surrogates" for disease
Petri dish
Lab-grown cells used in studies of human disease may not act as a faithful mimic of real tissue.

Studies of human disease rely on the use of cell cultures

Researchers at the University of Edinburgh have discovered that cell cultures, used in biology and medical research, may not act as a faithful mimic of real tissue.

The findings could affect the interpretation of past studies and provide important clues for improving cell cultures in the future.

Studies of human disease, including cancer, rely on the use of cell cultures that have often been grown for decades.

However, research led by the MRC Human Genetics Unit at the University of Edinburgh found that cells change within one week of growth in a laboratory dish.

The analysis provides new insight into how faithfully these cells mimic real tissue, and how models of human disease can still be improved.

Study author Richard Meehan from the MRC Human Genetics Unit at the University of Edinburgh, UK, said: “We were astonished by the speed and spread of the changes. Many cultured cells used in research have been grown for decades and as a result are likely to have very different properties from the cells they are supposed to model.  

"Our findings suggest that we have to be circumspect about the interpretation of some previous experiments, and our data reinforces a growing realisation that cell line models of human diseases, particularly cancer, can be poor surrogates for many aspects of in-vivo biology.”

The study, Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems, is published in Genome Biology.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.